<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000572228"><TermName>recombinant vaccinia-TRICOM vaccine</TermName><TermPronunciation>(ree-KOM-bih-nunt vak-SIH-nee-uh … vak-SEEN)</TermPronunciation><TermDefinition><DefinitionText>A cancer vaccine made with a form of a vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins that may help immune cells in the body kill tumor cells. Also called rV-TRICOM and vaccinia-TRICOM vaccine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720761" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;recombinant vaccinia-TRICOM vaccine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720760" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vacuna TRICOM recombinante de vaccinia&quot;" language="es" id="_4"/><SpanishTermName>vacuna TRICOM recombinante de vaccinia</SpanishTermName><SpanishTermDefinition><DefinitionText>Vacuna contra el cáncer elaborada con una forma del virus de vaccinia que no causa enfermedad en los seres humanos. Está en estudio para el tratamiento de algunos tipos de cáncer. El virus se altera en el laboratorio para producir proteínas humanas que pueden ayudar a que las células inmunitarias del cuerpo destruyan las células tumorales. También se llama rV-TRICOM y vacuna-TRICOM de vaccinia.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-04</DateFirstPublished></GlossaryTerm>
